IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients – a cohort studyGaya Spolverato, Salvatore Pucciarelli, Anna Pozza et al.|International Journal of Surgery|2023Cited by 11
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Matteo Fassan et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Daunia Verdi, Cesare Ruffolo et al.|Surgery|2024Cited by 2
726 IMMUNOREACT 8: IMMUNE MARKERS AS PREDICTORS OF LOCAL TUMOR SPREAD IN PATIENTS UNDERGOING TRANSANAL EXCISION FOR RECTAL CANCERGiulia Becherucci, Marco Scarpa, Cesare Ruffolo et al.|Gastroenterology|2023Cited by 0
67 IMMUNOREACT 9: METACHRONOUS RECTAL CANCER ARE FREQUENTLY FROM PREVIOUS RECTAL OR SIGMOID CANCER AND HAVE A LOW INFILTRATION OF CD8+ T CELLSBeatrice Salmaso, Marco Scarpa, Melania Scarpa et al.|Gastroenterology|2023Cited by 0